Canopy Biosciences
Saint Louis, US · Founded 2016 · Delaware LLC · 319 employees on LinkedIn · 2 known investors
Canopy Biosciences (Bruker Spatial Biology) develops spatial biology instruments and assays for analyzing gene expression, RNA, and proteins in tissue samples. The company serves research institutions, academic medical centers, and clinical laboratories studying oncology, biomarker discovery, and disease mechanisms.
Founders & leadership
EW
EDWARD WEINSTEINPresident, Chief Executive Officer and Manager
CW
CRYSTAL WINKELERChief Operating OfficerManaging Director at BioGenerator Ventures
CB
CHARLES BOLTENNamed on SEC filing
DK
DAVID KINGSLEYNamed on SEC filing
Board
DS
Investors · 2
Reported raises · per SEC filings
Form D private placements$3.2M disclosed across 2 rounds · 2016–2017
▶$2.1MraisedJan 2018 · 16 investors · BiotechnologyRule 506(b)
▶$2.1MraisedJan 2018 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- CHARLES BOLTENDirector
- CRYSTAL WINKELERExecutive Officer
- EDWARD WEINSTEINExecutive Officer, Director
- DAVID SMOLLERDirector
- DAVID KINGSLEYDirector
- Offering amount
- $3.4M
- Amount sold
- $2.1M
- Minimum investment
- $20K
- First sale
- Dec 2017
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
▶$1.1MraisedJul 2017 · 15 investors · BiotechnologyRule 506(b)
▶$1.1MraisedJul 2017 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- EDWARD WEINSTEINExecutive Officer, Director
- DAVID SMOLLERDirector
- CRYSTAL WINKELERExecutive Officer
- CHARLES BOLTENDirector
- DAVID KINGSLEYDirector
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- Minimum investment
- $20K
- First sale
- Oct 2016
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Canopy Biosciences do?
- Canopy Biosciences (Bruker Spatial Biology) develops spatial biology instruments and assays for analyzing gene expression, RNA, and proteins in tissue samples. The company serves research institutions, academic medical centers, and clinical laboratories studying oncology, biomarker discovery, and disease mechanisms.
- Who are Canopy Biosciences's investors?
- Canopy Biosciences's investors include Ampersand, BioGenerator Ventures.
- How much funding has Canopy Biosciences raised?
- Canopy Biosciences has disclosed $3.2M raised across 2 rounds.
- Where is Canopy Biosciences headquartered?
- Canopy Biosciences is headquartered in Saint Louis, US.